2015. [Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 16, 4 (Dec. 2015), 93–102. DOI:https://doi.org/10.7175/fe.v16i4.1221.